| Literature DB >> 30124349 |
Denggui Wen1, Wendi Zou2, Xiaoduo Wen3, Yi Yang3, Yuetong Chen1, Yutong He1, Guiying Wang1, Baoen Shan1.
Abstract
Objective To study urban-rural disparity in colorectal cancer incidence and the increasing trend in relation to rapid socioeconomic development and urbanization in China. Methods We compared the age-standardized incidence rates (ASRs) of colorectal cancer between rural and urban areas in China in 2012 and analyzed the trend in Shexian County for 2000-2015 using population-based tumor registration data collected in Shijiazhuang city (2012) and Shexian County (2000-2015). Results The ASRs of colorectal cancer in Shijiazhuang (urban) were considerably higher than in Shexian (rural) in both men (22.8 vs. 11.9/100,000) and women (15.0 vs. 9.3/100,000). The difference was similar to that between countries with high and medium human development indices according to GLOBOCAN 2012. In trend analysis, the biennial ASR in Shexian increased from 6.6 in 2000-2001 to 15.9/100,000 in 2014-2015 in men (averaged biennial percent change (ABPC) = +6.0%), and from 4.0 to 11.7/100,000 in women (ABPC=+5.5%). Conclusions The incidence of colorectal cancer in China is rising in parallel with socioeconomic development and urbanization. Integrated efforts should be made to reduce the incidences of overweight and obesity in society to help prevent this increase.Entities:
Keywords: Colorectal cancer; food education; healthy food; obesity; overweight; socioeconomic development; urbanization
Mesh:
Year: 2018 PMID: 30124349 PMCID: PMC6166325 DOI: 10.1177/0300060518791090
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Geographic locations of urban Shijiazhuang city (upper right) at the foot of Taihang Mountain and Shexian County located 250 km southwest in the Taihang mountain ranges.
Comparison of demographic and lifestyle characteristics between urban Shijiazhuang and rural Shexian in 2012.
| Demographic | Urban Shijiazhuang | Rural Shexian |
|---|---|---|
| Population | 2,374,827[ | 408,995[ |
| Urban population % | 100%[ | 48%[ |
| Altitude (m above sea level) | 30–100[ | 1000[ |
| Latitude N | 37°27′–38°47′[ | 36°17′–36°55′[ |
| GDP per capita | USD 6964.8[ | USD 2700[ |
| Annual disposable income per capita | USD 1538[ | USD 750[ |
| Annual disposable income spent on diet | 40%[ | 20%[ |
| Animal products in diet | >30%[ | <10%[ |
| Household automobile | 40%[ | 12%[ |
| People regularly doing exercise | 60%[ | 10%[ |
| People doing physical work | 20%[ | 70%[ |
| Daily smokers (men 2010) | 35%[ | 40%[ |
| Habitual alcohol drinkers (men 2010) | 38%[ | 25%[ |
| Overweight (BMI ≥24 kg/m2) (18–69 years, men 2010) | 43.7%[ | 30.2%[ |
| Overweight (BMI ≥24) (18–69 years, female 2010) | 36.7%[ | 35.4%[ |
| Obese (BMI ≥28) (18–69 years, men 2010) | 19.9%[ | 14.5%[ |
| Obese (BMI ≥28) (18–69 years, women 2010) | 23.2%[ | 17.1%[ |
| People aged under 25 years | 31.5%[ | 36.3%[ |
| People aged 65 years or over | 11.2%[ | 7.0%[ |
| Life expectancy in 2012 (years) | 75[ | 71[ |
BMI, body mass index.
Figure 2.Comparison of population pyramids for rural Shexian County and urban Shijiazhuang city in 2012.
Comparison of colorectal cancer incidence rates among urban Shijiazhuang, rural Shexian County, urban China (77 Chinese tumor registration cities), and rural China (100 Chinese rural counties).
| Age group (years) | Shijiazhuang 2012 | 77 Chinese cities 2011[8] | Shexian County | 100 Rural counties[8] 2011* | ||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | Male | Female | |
| 0 – <1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 1 – <5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| 5 – <10 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| 10 – <15 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| 15 – <20 | 0.0 | 0.0 | 0.4 | 0.3 | 0.0 | 0.0 | 0.1 | 0.2 |
| 20 – <25 | 0.0 | 0.0 | 1.0 | 0.7 | 0.0 | 0.0 | 0.9 | 0.6 |
| 25 – <30 | 0.0 | 2.8 | 1.3 | 1.6 | 0.0 | 0.0 | 1.3 | 1.2 |
| 30 – <35 | 3.4 | 2.1 | 3.2 | 2.4 | 7.4 | 0.0 | 2.6 | 2.8 |
| 35 – <40 | 5.1 | 2.9 | 5.8 | 5.3 | 7.6 | 0.0 | 5.5 | 4.8 |
| 40 – <45 | 25.7 | 11.5 | 11.2 | 9.6 | 10.9 | 0.0 | 9.6 | 8.3 |
| 45 – <50 | 25.6 | 21.3 | 20.9 | 17.9 | 16.8 | 5.8 | 19.0 | 13.4 |
| 50 – <55 | 34.8 | 30.6 | 38.0 | 29.2 | 22.8 | 16.4 | 27.6 | 20.3 |
| 55 – <60 | 66.6 | 43.1 | 64.0 | 43.7 | 32.8 | 24.6 | 45.0 | 31.4 |
| 60 – <65 | 91.5 | 64.0 | 98.2 | 64.4 | 44.7 | 50.3 | 66.7 | 43.8 |
| 65 – <70 | 121.5 | 81.0 | 124.9 | 87.5 | 66.7 | 64.2 | 80.3 | 53.7 |
| 70 – <75 | 208.1 | 111.8 | 180.7 | 127.5 | 73.4 | 85.1 | 106.0 | 73.1 |
| 75 – <80 | 218.9 | 140.7 | 234.7 | 162.1 | 117.5 | 111.0 | 134.8 | 88.6 |
| 80 – <85 | 123.5 | 83.6 | 264.9 | 173.5 | 86.6 | 74.8 | 127.8 | 86.0 |
| 85+ | 103.2 | 16.7 | 231.2 | 150.1 | 0.0 | 0.0 | 115.7 | 75.3 |
| Crude rate (1/105) | 33.2 | 21.6 | 31.7 | 24.7 | 13.7 | 11.1 | 19.8 | 15.2 |
| ASR (1/105) | 22.8 | 14.9 | 23.3 | 16.5 | 11.9 | 9.3 | 15.3 | 10.7 |
| Cum rate 0–74 years (%) | 2.9 | 1.9 | 2.8 | 2.0 | 1.4 | 1.2 | 1.8 | 1.3 |
ASR, age-standardized incidence rate; Cum rate, cumulative rate.
Comparison of age-standardized incidence rates of major cancer types between urban Shijiazhuang (men 1,157,390, women 1,217,437) and rural Shexian County (men 211,579, women 197,416) in 2012.
| Tumor site | Incidence rate (1/105) | Rank (%) | ASR (1/105) | ||||
|---|---|---|---|---|---|---|---|
| Shijiazhuang | Shexian | Shijiazhuang | Shexian | Shijiazhuang | Shexian |
| |
| Men | |||||||
| Lung (C33-34) | 67.9 | 33.4 | 1 (25.2) | 3 (9.3) | 46.5 | 30.0 | <0.01 |
| Stomach (C16) | 40.5 | 180.4 | 2 (15.1) | 1 (50.2) | 28.5 | 162.0 | <0.01 |
| Colorectal (C18-21) | 32.9 | 13.7 | 3 (12.2) | 5 (3.7) | 22.8 | 11.9 | <0.01 |
| Liver (C22) | 24.1 | 21.3 | 4 (9.0) | 4 (5.9) | 17.4 | 18.5 | |
| Esophagus (C15) | 23.0 | 79.8 | 5 (8.5) | 2 (22.2) | 15.7 | 72.1 | <0.01 |
| Kidney (C64-66,68) | 9.9 | 2.3 | 6 (3.7) | 8 (0.6) | 6.9 | 2.2 | <0.05 |
| Prostate (C61) | 9.2 | 0.9 | 7 (3.4) | 10 (0.3) | 5.3 | 0.7 | <0.01 |
| Leukemia (C91-95) | 9.0 | 4.2 | 8 (3.3) | 6 (1.2) | 6.5 | 4.0 | <0.20 |
| Bladder (C67) | 8.7 | 2.3 | 9 (3.2) | 8 (0.6) | 5.8 | 3.0 | <0.20 |
| Lymphoma (C81-85,88,90,96) | 8.6 | 3.7 | 10 (3.2) | 7 (1.0) | 6.3 | 3.1 | <0.10 |
| Pancreas (C25) | 4.3 | 0.0 | 11 (1.6) | 11 (0.1) | 3.1 | 0.1 | <0.01 |
| Larynx (C32) | 3.4 | 1.9 | 12 (1.3) | 9 (0.5) | 2.4 | 1.6 | |
| Gallbladder (C23-24) | 3.3 | 1.9 | 13 (1.2) | 9 (0.5) | 2.4 | 1.6 | |
| Thyroid (C73) | 2.5 | 0.0 | 14 (0.9) | 11 (0.1) | 1.9 | 0.1 | <0.05 |
| Brain (C70-72) | 2.3 | 4.2 | 15 (0.9) | 6 (1.2) | 2.0 | 4.5 | <0.05 |
| Nasopharynx (C11) | 1.8 | 2.3 | 16 (0.7) | 8 (0.6) | 1.3 | 2.1 | |
| Bone (C40-41) | 1.2 | 4.2 | 17 (0.4) | 6 (1.2) | 0.9 | 4.1 | <0.01 |
| All male cancers | 269.1 | 359.5 | 100.0 | 100.0 | 187.5 | 325.2 | <0.01 |
| Women | |||||||
| Breast (C50) | 59.6 | 18.1 | 1 (28.7) | 5 (6.6) | 45.3 | 14.4 | <0.01 |
| Lung (C33-34) | 28.4 | 23.1 | 2 (13.7) | 4 (8.4) | 19.0 | 20.8 | |
| Colorectal (C18-21) | 21.4 | 11.1 | 3 (10.3) | 7 (4.0) | 14.9 | 9.3 | <0.05 |
| Stomach (C16) | 11.3 | 83.2 | 4 (5.4) | 1 (30.3) | 7.7 | 71.5 | <0.01 |
| Cervix (C53) | 10.8 | 32.1 | 5 (5.2) | 3 (11.7) | 8.4 | 25.0 | <0.01 |
| Corpus uteri (C54) | 10.4 | 9.0 | 6 (5.0) | 8 (3.3) | 7.9 | 7.0 | |
| Ovary (C56) | 9.2 | 3.0 | 7 (4.4) | 11 (1.1) | 7.0 | 2.1 | <0.05 |
| Lymphoma (C81-85,88,90,96) | 7.6 | 3.0 | 8 (3.7) | 11 (1.1) | 5.5 | 2.5 | <0.10 |
| Esophagus (C15) | 6.5 | 43.1 | 9 (3.1) | 2 (15.7) | 4.1 | 36.2 | <0.01 |
| Liver (C22) | 6.1 | 15.0 | 10 (2.9) | 6 (5.5) | 4.2 | 13.3 | <0.01 |
| Leukemia (C91-95) | 5.4 | 4.0 | 11 (2.6) | 10 (1.5) | 4.6 | 5.3 | |
| Thyroid (C73) | 4.9 | 1.0 | 12 (2.4) | 15 (0.4) | 3.9 | 0.8 | <0.05 |
| Kidney (C64-66,68) | 4.9 | 0.5 | 2.4 | 0.2 | 3.9 | 0.5 | <0.05 |
| Pancreas (C25) | 3.6 | 1.0 | 1.7 | 0.4 | 2.4 | 0.8 | <0.10 |
| Bladder (C67) | 1.7 | 2.0 | 1.7 | 0.2 | 1.4 | 2.0 | |
| Gallbladder (C23-24) | 1.6 | 2.5 | 0.8 | 0.9 | 1.3 | 2.3 | |
| Brain (C70-72) | 1.0 | 9.0 | 0.5 | 3.3 | 1.0 | 7.3 | <0.01 |
| Bone (C40-41) | 0.9 | 4.5 | 0.4 | 1.6 | 0.8 | 4.0 | <0.01 |
| Nasopharynx (C11) | 0.7 | 0.0 | 0.4 | 0.0 | 0.7 | 0.0 | |
| Larynx (C32) | 0.1 | 1.5 | 0.0 | 0.5 | 0.1 | 1.1 | <0.01 |
| All female cancers | 207.6 | 274.2 | 100.0 | 100.0 | 150.4 | 230.7 | <0.01 |
*According to approximate method for comparing disease incidences between two groups.[16]
Figure 3.Age-standardized incidence rate of colorectal cancer in urban Shijiazhuang and rural Shexian in 2012 as compared with Chinese national data and GLOBOCAN 2012.
Biennial age-standardized incidence rates of major cancer sites between 2000 and 2015, average biennial percent change, and trends in Shexian County*
| Cancer (ICD-10) | Age-standardized incidence rate (1/105) | ABPC1-8* | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2000–2001 | 2002–2003 | 2004-2005 | 2006–2007 | 2008–2009 | 2010–2011 | 2012–2013 | 2014–2015 | |||
| Men | ||||||||||
| All cancers | 378.2 | 402.6 | 414.1 | 385.6 | 363.4 | 336.1 | 306.4 | 283.0 | −2.5 | 0.001** |
| Stomach (C16) 37.5% | 196.1 | 191.8 | 209.0 | 181.9 | 174.2 | 150.0 | 136.1 | 130.1 | −3.4 | 0.001** |
| Esophagus (C15) | 117.4 | 128.5 | 108.9 | 94.1 | 84.8 | 75.2 | 61.3 | 52.0 | −6.0 | 0.001** |
| Liver (C22) | 20.6 | 25.5 | 28.5 | 33.0 | 24.1 | 23.6 | 20.8 | 16.0 | −2.4 | 0.20 |
| Lung (C33-34) | 15.9 | 24.6 | 32.3 | 32.6 | 29.5 | 28.3 | 31.6 | 34.7 | 2.8 | 0.05* |
| Colorectal (C18-21) | 6.6 | 8.6 | 11.5 | 10.2 | 18.5 | 20.5 | 16.4 | 15.9 | 6.0 | 0.001** |
| Larynx (C32) | 5.5 | 3.8 | 2.7 | 4.2 | 3.6 | 4.0 | 2.9 | 1.9 | −4.4 | 0.001** |
| Brain (C70-72) | 3.9 | 3.3 | 4.6 | 4.9 | 3.9 | 4.3 | 6.9 | 3.3 | 2.0 | 0.40 |
| Leukemia (C91-95) | 2.8 | 4.3 | 2.1 | 3.8 | 3.9 | 5.2 | 5.9 | 7.7 | 7.4 | 0.001** |
| Pancreas (C25) | 1.9 | 0.9 | 0.7 | 1.6 | 2.4 | 2.5 | 2.0 | 3.4 | 6.5 | 0.10 |
| Bladder (C67) | 0.6 | 2.1 | 3.0 | 2.8 | 3.7 | 2.1 | 3.0 | 2.3 | 0.4 | 0.90 |
| Lymphoma (C81-85,88,90,96) | 1.6 | 1.9 | 3.5 | 3.8 | 3.2 | 4.3 | 3.3 | 2.9 | 3.0 | 0.20 |
| Bone (C40-41) | 1.0 | 1.5 | 0.7 | 4.3 | 1.8 | 4.1 | 2.8 | 2.1 | 4.2 | 0.40 |
| Prostate (C61) | 0.6 | 0.3 | 0.3 | 0.6 | 1.5 | 1.2 | 0.7 | 1.2 | 6.4 | 0.10 |
| Nasopharynx (C11) | 0.4 | 0.6 | 1.1 | 1.3 | 0.8 | 2.3 | 1.4 | 0.5 | 0.4 | 0.90 |
| Kidney (C64-66,68) | 0.2 | 0.3 | 2.1 | 1.3 | 1.3 | 1.3 | 2.1 | 2.9 | 9.0 | 0.10 |
| Thyroid (C73.9) | 0.2 | 0.3 | 0.9 | 0.2 | 0.5 | 0.8 | 0.8 | 1.5 | 3.2 | 0.10 |
| Gallbladder (C23-24) | 0.1 | 0.2 | 0.5 | 0.7 | 2.3 | 0.4 | 2.3 | 2.4 | 28.7 | 0.001* |
| Women | ||||||||||
| All cancers | 238.5 | 228.6 | 223.2 | 241.6 | 204.4 | 198.6 | 201.2 | 193.6 | −1.6 | 0.001** |
| Stomach (C16) | 114.5 | 98.7 | 81.7 | 79.0 | 61.3 | 57.9 | 57.0 | 46.4 | −6.0 | 0.001** |
| Esophagus (C15) | 74.1 | 55.9 | 58.0 | 59.0 | 40.0 | 38.8 | 34.1 | 34.0 | −5.5 | 0.001** |
| Liver (C22) | 13.1 | 17.6 | 15.1 | 14.6 | 10.4 | 9.0 | 6.3 | 5.9 | −7.1 | 0.001** |
| Cervix (C53) | 11.3 | 19.9 | 19.4 | 28.3 | 27.2 | 28.4 | 27.7 | 23.5 | 2.2 | 0.10 |
| Lung (C33-34) | 9.6 | 10.9 | 10.0 | 14.4 | 12.5 | 10.9 | 13.9 | 16.7 | 3.4 | 0.001** |
| Colorectal (C18-21) | 4.0 | 5.7 | 8.9 | 7.7 | 9.4 | 8.4 | 11.1 | 11.7 | 5.5 | 0.001** |
| Breast (C50) | 2.8 | 5.5 | 5.5 | 12.6 | 15.1 | 15.5 | 18.1 | 17.3 | 10.2 | 0.001** |
| Leukemia (C91-95) | 2.3 | 2.2 | 2.5 | 3.9 | 2.9 | 3.4 | 5.1 | 6.2 | 7.9 | 0.001** |
| Larynx (C32) | 1.4 | 1.5 | 2.3 | 1.6 | 0.5 | 0.7 | 0.7 | 0.5 | −10.0 | 0.001** |
| Uterus (C54-55) | 0.8 | 3.2 | 4.2 | 3.6 | 5.8 | 2.5 | 4.7 | 4.6 | 7.8 | 0.30 |
| Bladder (C67) | 0.3 | 0.7 | 0.9 | 2.1 | 0.5 | 0.2 | 1.6 | 0.9 | 5.7 | 0.70 |
| Pancreas (C25) | 0.8 | 0.3 | 0.6 | 1.1 | 1.1 | 1.5 | 1.0 | 1.0 | 4.1 | 0.10 |
| Brain (C70-72) | 0.7 | 0.6 | 4.1 | 2.8 | 3.3 | 5.6 | 4.9 | 5.2 | 18.5 | 0.10 |
| Lymphoma (C81-85,88,90,96) | 1.0 | 2.6 | 2.2 | 2.1 | 2.8 | 2.3 | 1.8 | 2.3 | 1.2 | 0.60 |
| Gallbladder (C23-24) | 0.3 | 0.6 | 0.4 | 0.4 | 1.4 | 2.1 | 1.4 | 2.7 | 15.6 | 0.001* |
| Bone (C40-41) | 0.1 | 0.9 | 1.6 | 1.2 | 1.0 | 1.0 | 1.4 | 0.7 | 24.5 | 0.001** |
| Nasopharynx (C11 | 0.2 | 0.6 | 0.6 | 0.9 | 0.3 | 0.5 | 0.6 | 0.6 | 0.10 | 0.90 |
| Kidney (C64-66,68) | 0.0 | 0.2 | 0.6 | 0.9 | 0.7 | 0.9 | 1.7 | 2.4 | 16.2 | 0.001** |
| Ovary (C56) | 0.2 | 0.3 | 1.7 | 1.2 | 3.5 | 2.7 | 3.3 | 4.3 | 12.4 | 0.001** |
| Thyroid (C73.9) | 0.2 | 0.2 | 1.5 | 0.9 | 2.5 | 1.5 | 2.1 | 4.2 | 23.4 | 0.001** |
ABPC, average biennial percent change.
Figure 4.Trends in biennial age-standardized incidence rates of colorectal cancer in rural Shexian County between 2000 and 2015 by Joinpoint version 4.2.0.2 with join point set at zero (1: men, P<0.001; 2: women, P<0.001).